GlaxoSmithKline Pharmaceuticals Limited has formally identified the key personnel authorized to determine the materiality of corporate events and transactions. This governance update ensures streamlined communication and transparent disclosure practices with stock exchanges. The appointed committee includes senior leadership members responsible for legal, financial, and administrative oversight to maintain compliance and effective stakeholder engagement.
Designated Key Personnel
As part of its ongoing governance framework, GlaxoSmithKline Pharmaceuticals Limited has authorized a team of senior officials responsible for evaluating the materiality of corporate information. This initiative ensures that significant events are assessed accurately and disclosed to the relevant authorities in a timely and professional manner.
Leadership Committee
The company has appointed the following individuals to oversee these disclosures, effective April 21, 2026:
- Mr. Bhushan Akshikar, Managing Director
- Mr. Ronojit Biswas, Whole-time Director & Chief Financial Officer
- Mr. Ajay Nadkarni, Company Secretary
- Mr. Amit Pandey, Head of Legal
Commitment to Transparency
By empowering this group of executives, the organization maintains a robust system for managing its public disclosures. This structured approach provides clarity in corporate communication and reinforces the company’s commitment to maintaining high standards of transparency with its investors and the public markets.
Source: BSE
